Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
&NA;
1994.
Antipsychotics.
Reactions Weekly,
Vol. &NA;,
Issue. 525,
p.
3.
Kohen, D.
and
Bristow, M.
1996.
Neuroleptic malignant syndrome.
Advances in Psychiatric Treatment,
Vol. 2,
Issue. 4,
p.
151.
Kopala, Lili C.
and
Caudle, Christopher
1998.
Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia.
Journal of Psychopharmacology,
Vol. 12,
Issue. 3,
p.
314.
Berardi, Domenico
Amore, Mario
Keck, Paul E
Troia, Mario
and
Dell’Atti, Maddalena
1998.
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study.
Biological Psychiatry,
Vol. 44,
Issue. 8,
p.
748.
Bahro, M.
Kämpf, C.
and
Strnad, J.
1999.
Catatonia under medication with risperidone in a 61‐year‐old patient.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 3,
p.
223.
Alao, Adekola O
Yolles, Jennifer C
Armenta, Wendy
and
Michaels, Anne T
1999.
Neuroleptic Malignant Syndrome Spectrum: A Case Report.
Journal of Pharmacy Technology,
Vol. 15,
Issue. 5,
p.
162.
Huang, Tiao‐Lai
Ree, Shao‐Chun
Huang, Yu‐Chu
Liu, Hia‐Yih
and
Yang, Yong‐Yi
1999.
Catatonic features: Differential diagnosis and treatments at an emergency unit.
Psychiatry and Clinical Neurosciences,
Vol. 53,
Issue. 1,
p.
63.
White, Denise A. C.
and
Robins, Ashley H.
2000.
An Analysis of 17 Catatonic Patients Diagnosed With Neuroleptic Malignant Syndrome.
CNS Spectrums,
Vol. 5,
Issue. 7,
p.
58.
Carey, S. J.
Hall, D. J.
and
Jones, G. A.
2002.
Grand rounds: catatonia.
Psychiatric Bulletin,
Vol. 26,
Issue. 2,
p.
68.
Berardi, Domenico
Dell'Atti, Maddalena
Amore, Mario
De Ronchi, Diana
and
Ferrari, Giuseppe
2002.
Clinical risk factors for neuroleptic malignant syndrome.
Human Psychopharmacology: Clinical and Experimental,
Vol. 17,
Issue. 2,
p.
99.
Kontaxakis, Vassilis P.
Havaki-Kontaxaki, Beata J.
Stamouli, Sophia S.
and
Christodoulou, George N.
2002.
Toxic interaction between risperidone and clozapine: A case report.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 26,
Issue. 2,
p.
407.
Ananth, Jambur
Aduri, Kamala
Parameswaran, Sharath
and
Gunatilake, Sarath
2004.
Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment.
Acta Neuropsychiatrica,
Vol. 16,
Issue. 4,
p.
219.
Lesch, Klaus-Peter
and
Heils, Armin
2004.
Bewegungsstörungen bei Psychischen Erkrankungen.
p.
61.
White, Suzanne R.
2005.
Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome.
Journal of Pharmacy Practice,
Vol. 18,
Issue. 3,
p.
175.
Rajagopal, Sundararajan
2007.
Catatonia.
Advances in Psychiatric Treatment,
Vol. 13,
Issue. 1,
p.
51.
Barnardo, Adrian
Pathmanaban, Omar
Dawood, Nagum
and
Anderson, Simon
2007.
Respiratory Failure Secondary to Malignant Catatonia and Klinefelter Pulmonary Deficits.
The Journal of ECT,
Vol. 23,
Issue. 4,
p.
286.
Ahuja, Niraj
and
Cole, Andrew J.
2009.
Hyperthermia syndromes in psychiatry.
Advances in Psychiatric Treatment,
Vol. 15,
Issue. 3,
p.
181.
Chandran, M
and
El-Shazly, M
2009.
Catatonia, neuroleptics and brain damage – a case report.
Journal of Psychopharmacology,
Vol. 23,
Issue. 2,
p.
223.
Saini, Suriati Mohamed
Eu, Choon Leng
Wan Yahya, Wan Nur Nafisah
and
Abdul Rahman, Abdul Hamid
2013.
Malignant catatonia secondary to viral meningoencephalitis in a young man with bipolar disorder.
Asia-Pacific Psychiatry,
Vol. 5,
Issue. S1,
p.
55.
Mazzone, Luigi
Postorino, Valentina
Valeri, Giovanni
and
Vicari, Stefano
2014.
Catatonia in Patients with Autism: Prevalence and Management.
CNS Drugs,
Vol. 28,
Issue. 3,
p.
205.
eLetters
No eLetters have been published for this article.